English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18074/20272 (89%)
造訪人次 : 4079180      線上人數 : 1150
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32598


    標題: High exposure to statins decrease the risk of new-onset dementia A nationwide population-based longitudinal cohort study
    作者: Chang, Chih-Feng
    Liou, Yi-Sheng
    Lin, Tsung-Kun
    Ma, Stacey
    Hu, Yu-Ru
    Chen, Hung-Yi
    Jong, Gwo-Ping
    貢獻者: Armed Force Taichung Gen Hosp, Div Cardiol, Dept Internal Med
    Natl Def Med Ctr
    Taichung Vet Gen Hosp, Dept Family Med
    Natl Def Med Ctr, Sch Publ Hlth
    Med Affairs Bur, Armed Forces Med Supplies Off
    Univ Calif San Diego, La Jolla
    Chia Nan Univ Pharm & Sci, Div Nutr
    China Med Univ, Inst Pharm
    Chung Shan Med Univ Hosp, Div Internal Cardiol
    Chung Shan Med Univ, 110,Sect 1,Chien Kuo N Rd
    關鍵字: high exposure to statins
    hyperlipidemia
    new-onset dementia
    日期: 2019-08
    上傳時間: 2020-07-29 13:51:27 (UTC+8)
    出版者: LIPPINCOTT WILLIAMS & WILKINS
    摘要: Several studies have shown that statin users have a lower risk of new-onset dementia (NOD) compared nonusers. However, other studies have shown opposite results. In this study, we investigated the association between the use of statins and the development of NOD. This was a longitudinal cohort study using data from claim forms submitted to the Taiwanese Bureau of National Health Insurance. The study included patients with NOD and non-NOD subjects from January 2002 to December 2013. We estimated the hazard ratios (HRs) of NOD associated with statin use, whereas nonuser subjects were used as a reference group. A total of 19,522 NOD cases were identified in 100,610 hyperlipidemic patients during the study period. The risk of NOD, after adjusting for sex, age, comorbidities, and concurrent medication, was lower among statin users than nonusers (HR 0.95, 95% CI [ confidence interval] 0.94-0.96; P<. 001). The adjusted HRs for NOD were 1.53 (95% CI, 1.45-1.62), 0.63 (95% CI, 0.57-0.71), and 0.34 (95% CI, 0.30-0.38) when the cumulative defined daily doses ranged from 28 to 365, 366 to 730, and more than 730 relative to nonusers, respectively. Weconcluded that statin use is associated with a decreasedNODrisk. The protective effect of statins forNODseemedto be related to high exposure to statins. This study also highlights that high exposure to statins has a dose-response effect on lowering NOD risk.
    關聯: Medicine, v.98, n.34, e16931
    顯示於類別:[保健營養系(所) ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML1126檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋